BDNF and depressive symptom measurement: Our scoping review findings support BDNF’s longstanding role as a marker of exercise/PA response since its discovery in 1982 [84,85] and suggest a potential connection between BDNF changes and symptom improvements, such as reductions in fatigue, pain, and depression.